Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

  • Stage: Pre-A轮。

About the Company

[Summary] 新一代蛋白降解剂药物研发商

阿泰克是聚焦全球首创的新一代蛋白降解药物研发的公司。公司独辟蹊径,聚焦全新自噬溶酶体靶向降解的小分子胶水新药,致力于为“无法靶向”的致病蛋白或“不可成药”的靶点提供全新治疗方案。围绕重大未满足临床需求,储备了多个在研产品管线,并拥有自主知识产权。阿泰克是少数聚焦ATTEC技术的蛋白降解剂企业,其ATTEC小分子胶水筛选技术,能高通量、高效率、低成本完成靶点筛选。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

阿泰克生物 Financing History (4 rounds)

Manage
Pre-A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 红杉资本中国

阿泰克生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,462.766万(元)
Legal Representative: 胡炜
Date Established:
Credit Code: 91330104MA2H0RJA2R
Registered Address: 浙江省杭州市余杭区良渚街道通运街366号1幢110室

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

室内娱乐
客服
由百度提供